Victory Capital Management Inc Mannkind Corp Transaction History

Victory Capital Management Inc

$95.7 Billion
Q4 2024

A detailed history of Victory Capital Management Inc transactions in Mannkind Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 219,367 shares of MNKD stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,367

Previous 47,830 358.64%

Holding current value

$1.22 Million

Previous $300,000 370.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$5.93 - $7.44 $1.02 Million - $1.28 Million	171,537 Added 358.64%	219,367 $1.41 Million
Q3 2024 Nov 05, 2024	BUY	$5.01 - $6.7 $69,253 - $92,614	13,823 Added 40.65%	47,830 $300,000
Q2 2024 Aug 05, 2024	SELL	$4.05 - $5.43 $1,040 - $1,395	-257 Reduced 0.75%	34,007 $177,000
Q1 2024 May 03, 2024	SELL	$3.25 - $5.27 $2,600 - $4,216	-800 Reduced 2.28%	34,264 $155,000
Q4 2023 Feb 05, 2024	BUY	$3.34 - $4.29 $22,555 - $28,970	6,753 Added 23.85%	35,064 $127,000
Q3 2023 Nov 06, 2023	BUY	$3.91 - $5.45 $1,395 - $1,945	357 Added 1.28%	28,311 $116,000
Q2 2023 Jul 27, 2023	SELL	$3.72 - $4.79 $2,421 - $3,118	-651 Reduced 2.28%	27,954 $113,000
Q1 2023 May 02, 2023	BUY	$3.95 - $5.63 $4,546 - $6,480	1,151 Added 4.19%	28,605 $117,000
Q4 2022 Feb 10, 2023	BUY	$3.02 - $5.37 $748 - $1,331	248 Added 0.91%	27,454 $144,000
Q4 2022 Feb 09, 2023	SELL	$3.02 - $5.37 $782 - $1,390	-259 Reduced 0.94%	27,206 $143,000
Q3 2022 Nov 02, 2022	SELL	$2.99 - $4.35 $16,537 - $24,059	-5,531 Reduced 16.76%	27,465 $85,000
Q2 2022 Aug 01, 2022	SELL	$2.67 - $4.77 $138 - $248	-52 Reduced 0.16%	32,996 $126,000
Q1 2022 May 04, 2022	SELL	$2.62 - $4.45 $2,470 - $4,196	-943 Reduced 2.77%	33,048 $103,000
Q4 2021 Feb 07, 2022	SELL	$4.05 - $5.37 $1,867 - $2,475	-461 Reduced 1.34%	33,991 $149,000
Q3 2021 Nov 02, 2021	SELL	$3.89 - $5.48 $8,013 - $11,288	-2,060 Reduced 5.64%	34,452 $150,000
Q2 2021 Aug 03, 2021	SELL	$3.61 - $5.45 $2,974 - $4,490	-824 Reduced 2.21%	36,512 $199,000
Q1 2021 May 04, 2021	BUY	$3.14 - $6.14 $3,444 - $6,735	1,097 Added 3.03%	37,336 $146,000
Q4 2020 Feb 01, 2021	BUY	$1.79 - $4.04 $4,219 - $9,522	2,357 Added 6.96%	36,239 $113,000
Q3 2020 Nov 09, 2020	BUY	$1.56 - $2.08 $304 - $405	195 Added 0.58%	33,882 $64,000
Q2 2020 Aug 07, 2020	SELL	$0.94 - $2.21 $476 - $1,120	-507 Reduced 1.48%	33,687 $59,000
Q1 2020 May 04, 2020	BUY	$0.84 - $1.76 $158 - $332	189 Added 0.56%	34,194 $35,000
Q4 2019 Feb 04, 2020	BUY	$1.14 - $1.49 $2,528 - $3,304	2,218 Added 6.98%	34,005 $50,000
Q3 2019 Nov 12, 2019	BUY	$1.04 - $1.44 $33,058 - $45,773	31,787 New	31,787 $40,000

Others Institutions Holding MNKD

# of Institutions

255

Shares Held

150M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Mannkind Corp Transaction History